| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000003 | Reproduction | Decreases phenotype | PMID:26545148 |
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:29606031; PMID:30320191; PMID:36394428 |
| GO:0000084 | Mitotic s phase | Decreases phenotype | PMID:31163220 |
| GO:0000104 | Succinate dehydrogenase activity | Decreases phenotype | PMID:35510228 |
| GO:0000105 | Histidine biosynthetic process | Decreases phenotype | PMID:30284816 |
| GO:0000212 | Meiotic spindle organization | Affects phenotype | PMID:34492810 |
| GO:0000239 | Pachytene | Increases phenotype | PMID:28771232 |
| GO:0000240 | Diplotene | Decreases phenotype | PMID:28771232 |
| GO:0000266 | Mitochondrial fission | Increases phenotype | PMID:31408635 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:36608567 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:26845775; PMID:28771232; PMID:35521929; PMID:36356568; PMID:36394428 |
| GO:0001503 | Ossification | Affects phenotype | PMID:28921615 |
| GO:0001510 | Rna methylation | Increases phenotype | PMID:31923814; PMID:34120004 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:24458533; PMID:26678702; PMID:29969652; PMID:30939196; PMID:32209209; PMID:34597818; PMID:35762964 |
| GO:0001543 | Ovarian follicle rupture | Decreases phenotype | PMID:25888850 |
| GO:0001544 | Initiation of primordial ovarian follicle growth | Affects phenotype | PMID:28286118; PMID:34051340; PMID:34492810; PMID:39265699 |
| GO:0001546 | Preantral ovarian follicle growth | Increases phenotype | PMID:28286118; PMID:30939196 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:26845775; PMID:28013214 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:27495896; PMID:28286118; PMID:36774801 |
| GO:0001553 | Luteinization | Affects phenotype | PMID:26161573 |
| GO:0001556 | Oocyte maturation | Decreases phenotype | PMID:26545148 |
| GO:0001568 | Blood vessel development | Increases phenotype | PMID:37021957 |
| GO:0001649 | Osteoblast differentiation | Increases phenotype | PMID:28921615 |
| GO:0001675 | Acrosome assembly | Affects phenotype | PMID:32619501; PMID:36087924 |
| GO:0001824 | Blastocyst development | Decreases phenotype | PMID:40279284 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:22147016; PMID:27417426; PMID:28042535; PMID:28286118 |
| GO:0001843 | Neural tube closure | Decreases phenotype | PMID:28123099 |
| GO:0002027 | Regulation of heart rate | Affects phenotype | PMID:25799571; PMID:28842438 |
| GO:0002209 | Behavioral defense response | Affects phenotype | PMID:38152552 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:25093321 |
| GO:0002437 | Inflammatory response to antigenic stimulus | Increases phenotype | PMID:25093321 |
| GO:0002438 | Acute inflammatory response to antigenic stimulus | Increases phenotype | PMID:23148021 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:30691201 |
| GO:0002636 | Positive regulation of germinal center formation | Increases phenotype | PMID:25093321 |
| GO:0002830 | Positive regulation of type 2 immune response | Increases phenotype | PMID:36209858; PMID:36508822 |
| GO:0003006 | Developmental process involved in reproduction | Increases phenotype | PMID:29471507; PMID:37788136 |
| GO:0003016 | Respiratory system process | Decreases phenotype | PMID:30737192 |
| GO:0003093 | Regulation of glomerular filtration | Affects phenotype | PMID:32645486 |
| GO:0003229 | Ventricular cardiac muscle tissue development | Decreases phenotype | PMID:31086358 |
| GO:0003279 | Cardiac septum development | Decreases phenotype | PMID:31086358 |
| GO:0003993 | Acid phosphatase activity | Affects phenotype | PMID:25882133; PMID:26361869 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:30691201 |
| GO:0004022 | Alcohol dehydrogenase (nad+) activity | Decreases phenotype | PMID:34534558 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:26361869; PMID:28025108; PMID:28921615; PMID:31979393 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Affects phenotype | PMID:28025108; PMID:30691201; PMID:31979393 |
| GO:0004095 | Carnitine o-palmitoyltransferase activity | Decreases phenotype | PMID:30284816 |
| GO:0004345 | Glucose-6-phosphate dehydrogenase activity | Decreases phenotype | PMID:31606821 |
| GO:0004357 | Glutamate-cysteine ligase activity | Increases phenotype | PMID:30523571 |
| GO:0004457 | Lactate dehydrogenase activity | Decreases phenotype | PMID:26361869; PMID:30284816 |
| GO:0004565 | Beta-galactosidase activity | Increases phenotype | PMID:31160972 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:27084994; PMID:28065941; PMID:29328408; PMID:32303808; PMID:32884073; PMID:33484791; PMID:35196152; PMID:35196152; PMID:39360521; PMID:35659966; PMID:39360521 |
| GO:0004691 | Camp-dependent protein kinase activity | Increases phenotype | PMID:33711355 |
| GO:0004738 | Pyruvate dehydrogenase activity | Increases phenotype | PMID:30284816 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:25882133; PMID:25882133; PMID:26854921; PMID:29328408; PMID:26854921; PMID:27084994; PMID:28025108; PMID:28065941; PMID:28115068; PMID:29328408; PMID:30691201; PMID:33484791; PMID:31112013; PMID:35521929; PMID:31486570; PMID:32303808; PMID:33484791; PMID:34097988; PMID:34793900; PMID:35196152; PMID:35196152; PMID:39360521; PMID:35521929; PMID:35659966; PMID:39360521 |
| GO:0005739 | Mitochondrion | Increases phenotype | PMID:35659966 |
| GO:0005776 | Autophagosome | Affects phenotype | PMID:36394428 |
| GO:0005977 | Glycogen metabolic process | Increases phenotype | PMID:30565266; PMID:33484791 |
| GO:0006006 | Glucose metabolic process | Decreases phenotype | PMID:23277027; PMID:34303773; PMID:34600010 |
| GO:0006007 | Glucose catabolic process | Decreases phenotype | PMID:30597186 |
| GO:0006045 | N-acetylglucosamine biosynthetic process | Decreases phenotype | PMID:30284816 |
| GO:0006085 | Acetyl-coa biosynthetic process | Affects phenotype | PMID:33391822 |
| GO:0006094 | Gluconeogenesis | Decreases phenotype | PMID:30284816 |
| GO:0006096 | Glycolytic process | Increases phenotype | PMID:30284816 |
| GO:0006099 | Tricarboxylic acid cycle | Decreases phenotype | PMID:30284816 |
| GO:0006109 | Regulation of carbohydrate metabolic process | Affects phenotype | PMID:35550907 |
| GO:0006140 | Regulation of nucleotide metabolic process | Affects phenotype | PMID:35550907; PMID:37458746 |
| GO:0006171 | Camp biosynthetic process | Affects phenotype | PMID:32126385; PMID:33234378; PMID:37552060 |
| GO:0006172 | Adp biosynthetic process | Decreases phenotype | PMID:30550969 |
| GO:0006260 | Dna replication | Increases phenotype | PMID:32435917 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:38833407 |
| GO:0006325 | Chromatin organization | Affects phenotype | PMID:37302538 |
| GO:0006355 | Regulation of dna-templated transcription | Affects phenotype | PMID:25853433 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:26630026; PMID:35550907 |
| GO:0006537 | Glutamate biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0006542 | Glutamine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0006571 | Tyrosine biosynthetic process | Affects phenotype | PMID:31706747 |
| GO:0006590 | Thyroid hormone generation | Increases phenotype | PMID:31979393 |
| GO:0006601 | Creatine biosynthetic process | Increases phenotype | PMID:30284816 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:35818422 |
| GO:0006626 | Protein targeting to mitochondrion | Affects phenotype | PMID:31408635 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:28105114 |
| GO:0006633 | Fatty acid biosynthetic process | Decreases phenotype | PMID:30284816 |
| GO:0006635 | Fatty acid beta-oxidation | Decreases phenotype | PMID:30284816 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:22792086; PMID:23277027; PMID:28105114; PMID:32325186; PMID:33484791; PMID:23277027; PMID:28105114; PMID:33484791; PMID:26630026; PMID:30145988; PMID:32325186; PMID:33166671; PMID:33484791; PMID:33832334; PMID:36988346 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:25888850 |
| GO:0006694 | Steroid biosynthetic process | Decreases phenotype | PMID:35762964 |
| GO:0006695 | Cholesterol biosynthetic process | Decreases phenotype | PMID:30284816; PMID:31979393 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:25882133; PMID:32500380; PMID:35196152; PMID:35196152; PMID:39360521; PMID:35460826; PMID:35500696; PMID:35521929; PMID:39360521 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:26361869; PMID:26361869; PMID:26854921; PMID:26854921; PMID:28115068 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:25418486 |
| GO:0006900 | Vesicle budding from membrane | Increases phenotype | PMID:33229049 |
| GO:0006909 | Phagocytosis | Decreases phenotype | PMID:26133781 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:24393508; PMID:25068794; PMID:25418486; PMID:25975992; PMID:26845775; PMID:27084994; PMID:28042535; PMID:28532275; PMID:28532275; PMID:29606031; PMID:31163220; PMID:35659966; PMID:36394428; PMID:37302538; PMID:37406783; PMID:39515621 |
| GO:0006950 | Response to stress | Affects phenotype | PMID:28842438 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:35510228 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:24084170; PMID:26854921; PMID:28115068; PMID:29777724; PMID:29777724; PMID:31486570; PMID:30543897; PMID:34822940 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:21673306; PMID:30320191; PMID:34822940; PMID:35917956; PMID:36087924; PMID:36174316; PMID:39360521 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:35659966 |
| GO:0007033 | Vacuole organization | Affects phenotype | PMID:30320191; PMID:36087924 |
| GO:0007132 | Meiotic metaphase i | Affects phenotype | PMID:22147016 |
| GO:0007137 | Meiotic metaphase ii | Affects phenotype | PMID:28042535 |
| GO:0007144 | Female meiosis i | Affects phenotype | PMID:28771232 |
| GO:0007179 | Transforming growth factor beta receptor signaling pathway | Affects phenotype | PMID:37059381 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:28123099; PMID:30802670; PMID:37059381; PMID:37788136 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:18570050; PMID:22147016; PMID:23892333; PMID:25882133; PMID:25882133; PMID:29663635; PMID:29940330; PMID:27060630; PMID:27417426; PMID:29029336; PMID:31175881; PMID:32235866; PMID:35196152; PMID:36087924; PMID:36423848; PMID:29029336; PMID:29328408; PMID:29328408; PMID:30320191; PMID:34015638; PMID:29663635; PMID:29940330; PMID:30802670; PMID:31175881; PMID:32050098; PMID:32619501; PMID:33923623; PMID:37692514; PMID:35196152; PMID:36174316; PMID:36174712; PMID:37364641; PMID:38730545; PMID:39360521 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30802670 |
| GO:0007507 | Heart development | Decreases phenotype | PMID:29377175; PMID:31086358 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:40279284 |
| GO:0007568 | Aging | Increases phenotype | PMID:36174712 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:30523571; PMID:35354077; PMID:37858774 |
| GO:0007612 | Learning | Affects phenotype | PMID:37302538 |
| GO:0007613 | Memory | Decreases phenotype | PMID:37061009; PMID:37302538 |
| GO:0007614 | Short-term memory | Decreases phenotype | PMID:29688563 |
| GO:0007617 | Mating behavior | Decreases phenotype | PMID:36435455 |
| GO:0007625 | Grooming behavior | Decreases phenotype | PMID:26168342; PMID:35254616 |
| GO:0007626 | Locomotory behavior | Decreases phenotype | PMID:32303808 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:30078309; PMID:31979393; PMID:31979393; PMID:36087924 |
| GO:0008049 | Male courtship behavior | Affects phenotype | PMID:28934723 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:23277027; PMID:28105114; PMID:32325186; PMID:33484791; PMID:23756648; PMID:27827939; PMID:33166671; PMID:33484791; PMID:36988346 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:26630026; PMID:28611354; PMID:33309551; PMID:34597818 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:28842438 |
| GO:0008219 | Cell death | Increases phenotype | PMID:33711355; PMID:39360521 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:24213142; PMID:24213142; PMID:36328110; PMID:25068794; PMID:25418486; PMID:25995009; PMID:26630026; PMID:27853917; PMID:28054989; PMID:28115068; PMID:29663635; PMID:30078309; PMID:30543897; PMID:31175881; PMID:34186418; PMID:34428494; PMID:34728246; PMID:34801851; PMID:36328110; PMID:36608567; PMID:37302538; PMID:39109301 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:17929048; PMID:23793038; PMID:24496636; PMID:26519955; PMID:25369342; PMID:28412506; PMID:30090590; PMID:32681327; PMID:35263089; PMID:35810816; PMID:37734194 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30720231; PMID:31228551; PMID:31771930; PMID:32353385; PMID:32949729; PMID:33091774; PMID:34492810; PMID:35500696; PMID:35716406; PMID:35739755; PMID:35841924; PMID:36209858; PMID:36774801 |
| GO:0008344 | Adult locomotory behavior | Affects phenotype | PMID:29982774 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:36198370 |
| GO:0008542 | Visual learning | Decreases phenotype | PMID:29688563 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:23959011; PMID:28611354; PMID:29328408; PMID:30802670; PMID:39307383 |
| GO:0008585 | Female gonad development | Affects phenotype | PMID:26845775 |
| GO:0009094 | L-phenylalanine biosynthetic process | Affects phenotype | PMID:31706747 |
| GO:0009098 | Leucine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0009099 | Valine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0009100 | Glycoprotein metabolic process | Affects phenotype | PMID:33309551 |
| GO:0009117 | Nucleotide metabolic process | Affects phenotype | PMID:37458746 |
| GO:0009312 | Oligosaccharide biosynthetic process | Decreases phenotype | PMID:34600010 |
| GO:0009435 | Nad biosynthetic process | Decreases phenotype | PMID:36781136 |
| GO:0009448 | Gamma-aminobutyric acid metabolic process | Affects phenotype | PMID:29774754; PMID:32303808 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:33711355 |
| GO:0009749 | Response to glucose | Decreases phenotype | PMID:29175711 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:33711355 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:33872906; PMID:37120575 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:38995844 |
| GO:0010507 | Negative regulation of autophagy | Increases phenotype | PMID:38488668 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:31262386; PMID:32710958; PMID:36583613 |
| GO:0010511 | Regulation of phosphatidylinositol biosynthetic process | Affects phenotype | PMID:31577137 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:29669060; PMID:33229049 |
| GO:0010719 | Negative regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:31726466 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:36610486 |
| GO:0010867 | Positive regulation of triglyceride biosynthetic process | Increases phenotype | PMID:31606821; PMID:31706747; PMID:34303773; PMID:34600010; PMID:35019730; PMID:37753369; PMID:37753369; PMID:38050670 |
| GO:0010868 | Negative regulation of triglyceride biosynthetic process | Increases phenotype | PMID:38050670 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:32353385 |
| GO:0010893 | Positive regulation of steroid biosynthetic process | Decreases phenotype | PMID:27405655 |
| GO:0010894 | Negative regulation of steroid biosynthetic process | Increases phenotype | PMID:34492810 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:35739755; PMID:37364641 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:36583613 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Affects phenotype | PMID:23793038 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:37734194 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:27417426; PMID:30090590; PMID:35716406 |
| GO:0010983 | Positive regulation of high-density lipoprotein particle clearance | Increases phenotype | PMID:31606821 |
| GO:0010987 | Negative regulation of high-density lipoprotein particle clearance | Increases phenotype | PMID:30550969; PMID:35970509; PMID:31262386; PMID:31706747; PMID:31732953 |
| GO:0010989 | Negative regulation of low-density lipoprotein particle clearance | Increases phenotype | PMID:30550969; PMID:31262386; PMID:31606821; PMID:31706747; PMID:31732953; PMID:34303773; PMID:37753369 |
| GO:0014067 | Negative regulation of phosphatidylinositol 3-kinase signaling | Increases phenotype | PMID:32710958 |
| GO:0014068 | Positive regulation of phosphatidylinositol 3-kinase signaling | Affects phenotype | PMID:23793038 |
| GO:0015908 | Fatty acid transport | Decreases phenotype | PMID:30284816 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:26854921; PMID:28025108; PMID:28115068; PMID:31112013; PMID:31486570; PMID:33484791; PMID:34097988; PMID:35521929 |
| GO:0016049 | Cell growth | Increases phenotype | PMID:30543897; PMID:33526986 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:31923814; PMID:33649816 |
| GO:0016342 | Catenin complex | Decreases phenotype | PMID:36087924 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:36328110 |
| GO:0016788 | Hydrolase activity, acting on ester bonds | Increases phenotype | PMID:37406783 |
| GO:0016887 | Atp hydrolysis activity | Affects phenotype | PMID:30284816 |
| GO:0018108 | Peptidyl-tyrosine phosphorylation | Increases phenotype | PMID:33711355 |
| GO:0018158 | Protein oxidation | Affects phenotype | PMID:32500380; PMID:34793900; PMID:35196152 |
| GO:0018963 | Phthalate metabolic process | Increases phenotype | PMID:30078309; PMID:35354077; PMID:36933457 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:35550907; PMID:37806616; PMID:38199361 |
| GO:0019218 | Regulation of steroid metabolic process | Affects phenotype | PMID:28115639 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:30284816 |
| GO:0019432 | Triglyceride biosynthetic process | Affects phenotype | PMID:23756648; PMID:28433925; PMID:30284816; PMID:30722647 |
| GO:0019577 | Aldaric acid metabolic process | Affects phenotype | PMID:31706747 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:32500380 |
| GO:0019695 | Choline metabolic process | Decreases phenotype | PMID:32949613; PMID:34600010 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:39842396 |
| GO:0019852 | L-ascorbic acid metabolic process | Affects phenotype | PMID:31706747 |
| GO:0021983 | Pituitary gland development | Affects phenotype | PMID:34728246 |
| GO:0022602 | Ovulation cycle process | Decreases phenotype | PMID:29471507; PMID:29969652 |
| GO:0030010 | Establishment of cell polarity | Decreases phenotype | PMID:36608567 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:25882133; PMID:28611354; PMID:29029336 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:27996362 |
| GO:0030324 | Lung development | Decreases phenotype | PMID:28576411 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:33229049; PMID:36232341; PMID:37734194 |
| GO:0030534 | Adult behavior | Decreases phenotype | PMID:35354077 |
| GO:0030728 | Ovulation | Increases phenotype | PMID:25888850; PMID:33316053 |
| GO:0030850 | Prostate gland development | Decreases phenotype | PMID:30802670 |
| GO:0031016 | Pancreas development | Affects phenotype | PMID:21673306 |
| GO:0031394 | Positive regulation of prostaglandin biosynthetic process | Increases phenotype | PMID:35810816 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:35818324; PMID:38152552 |
| GO:0032008 | Positive regulation of tor signaling | Affects phenotype | PMID:23793038 |
| GO:0032024 | Positive regulation of insulin secretion | Increases phenotype | PMID:34600010; PMID:39265699 |
| GO:0032205 | Negative regulation of telomere maintenance | Increases phenotype | PMID:36174712 |
| GO:0032308 | Positive regulation of prostaglandin secretion | Increases phenotype | PMID:33316053 |
| GO:0032338 | Regulation of inhibin secretion | Affects phenotype | PMID:25296284 |
| GO:0032341 | Aldosterone metabolic process | Affects phenotype | PMID:21389346 |
| GO:0032469 | Endoplasmic reticulum calcium ion homeostasis | Affects phenotype | PMID:25418486 |
| GO:0032776 | Dna methylation on cytosine | Increases phenotype | PMID:25280772 |
| GO:0032790 | Ribosome disassembly | Increases phenotype | PMID:37858774 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:33348264 |
| GO:0033037 | Polysaccharide localization | Increases phenotype | PMID:37753369 |
| GO:0033132 | Negative regulation of glucokinase activity | Increases phenotype | PMID:31606821 |
| GO:0033212 | Iron import into cell | Increases phenotype | PMID:36438553; PMID:36696656; PMID:38050670 |
| GO:0033327 | Leydig cell differentiation | Decreases phenotype | PMID:27417426; PMID:29325824 |
| GO:0033684 | Regulation of luteinizing hormone secretion | Affects phenotype | PMID:32209209 |
| GO:0033685 | Negative regulation of luteinizing hormone secretion | Increases phenotype | PMID:34015638; PMID:37812459; PMID:37975621 |
| GO:0033686 | Positive regulation of luteinizing hormone secretion | Increases phenotype | PMID:34049116 |
| GO:0034113 | Heterotypic cell-cell adhesion | Decreases phenotype | PMID:38730545 |
| GO:0034199 | Activation of protein kinase a activity | Increases phenotype | PMID:37552060 |
| GO:0034255 | Regulation of urea metabolic process | Affects phenotype | PMID:32949613 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:25882133; PMID:25882133; PMID:29328408; PMID:32050098; PMID:29328408; PMID:30691201; PMID:32050098; PMID:32500380; PMID:35460826; PMID:35500696; PMID:35818324; PMID:36198370; PMID:36328110; PMID:39360521 |
| GO:0034599 | Cellular response to oxidative stress | Increases phenotype | PMID:38503103 |
| GO:0034729 | Histone h3-k79 methylation | Increases phenotype | PMID:37545493 |
| GO:0035116 | Embryonic hindlimb morphogenesis | Decreases phenotype | PMID:24503621 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:26168342; PMID:34781058; PMID:35254616 |
| GO:0035265 | Organ growth | Affects phenotype | PMID:30078309 |
| GO:0035360 | Positive regulation of peroxisome proliferator activated receptor signaling pathway | Increases phenotype | PMID:26519955 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:32303808; PMID:38152552 |
| GO:0035847 | Uterine epithelium development | Affects phenotype | PMID:36435455 |
| GO:0035934 | Corticosterone secretion | Increases phenotype | PMID:38152552 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:24393508; PMID:28013214; PMID:29688563; PMID:30802670; PMID:31175881; PMID:31199487; PMID:35259346; PMID:38730545 |
| GO:0035938 | Estradiol secretion | Affects phenotype | PMID:28013214; PMID:28637469 |
| GO:0035941 | Androstenedione secretion | Decreases phenotype | PMID:28013214 |
| GO:0035943 | Estrone secretion | Decreases phenotype | PMID:28013214 |
| GO:0036123 | Histone h3-k9 dimethylation | Decreases phenotype | PMID:25975992 |
| GO:0036126 | Sperm flagellum | Affects phenotype | PMID:36174316; PMID:39360521 |
| GO:0036145 | Dendritic cell homeostasis | Affects phenotype | PMID:33424850 |
| GO:0036162 | Oxytocin production | Decreases phenotype | PMID:34576011 |
| GO:0036211 | Protein modification process | Affects phenotype | PMID:39360521 |
| GO:0036269 | Swimming behavior | Decreases phenotype | PMID:32303808 |
| GO:0038028 | Insulin receptor signaling pathway via phosphatidylinositol 3-kinase | Decreases phenotype | PMID:35460826 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:32619501 |
| GO:0040016 | Embryonic cleavage | Decreases phenotype | PMID:22147016; PMID:28042535; PMID:28286118 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:33497755; PMID:33872906 |
| GO:0042221 | Response to chemical | Increases phenotype | PMID:34428494 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:28054989; PMID:28054989; PMID:28065941; PMID:28065941 |
| GO:0042412 | Taurine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0042427 | Serotonin biosynthetic process | Affects phenotype | PMID:32303808 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:30186573; PMID:34597818 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:34793900 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:30565266; PMID:30660623; PMID:31228551 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:35739755; PMID:35970509 |
| GO:0042692 | Muscle cell differentiation | Affects phenotype | PMID:24067726 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:25888850; PMID:33316053 |
| GO:0042711 | Maternal behavior | Decreases phenotype | PMID:34576011 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:31979393 |
| GO:0042759 | Long-chain fatty acid biosynthetic process | Increases phenotype | PMID:30284816 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:24646702; PMID:28082598; PMID:30755103; PMID:31160972; PMID:31228551; PMID:31920986; PMID:31923814; PMID:32710958; PMID:32619501; PMID:33091774; PMID:33162236; PMID:33511402; PMID:33754040; PMID:38008054; PMID:34492810; PMID:35716406; PMID:35739755; PMID:36583613; PMID:37059381; PMID:37364641; PMID:37734194; PMID:37979351; PMID:38008054; PMID:38488668; PMID:38522500 |
| GO:0043467 | Regulation of generation of precursor metabolites and energy | Affects phenotype | PMID:36516674 |
| GO:0043966 | Histone h3 acetylation | Increases phenotype | PMID:37545493 |
| GO:0043967 | Histone h4 acetylation | Increases phenotype | PMID:37545493 |
| GO:0044029 | Hypomethylation of cpg island | Increases phenotype | PMID:30691201 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:25853433; PMID:32864567 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:25418486; PMID:26445464; PMID:27084994; PMID:27853917; PMID:28065941; PMID:28367427; PMID:30120713; PMID:31112013; PMID:35521929; PMID:31163220; PMID:31408635; PMID:34822940; PMID:35457000; PMID:35521929; PMID:35659966; PMID:35887207; PMID:36328110; PMID:36394428; PMID:36674557; PMID:37302538; PMID:39515621 |
| GO:0044524 | Protein sulfhydration | Decreases phenotype | PMID:31486570 |
| GO:0044849 | Estrous cycle | Decreases phenotype | PMID:29471507; PMID:30186573; PMID:32209209; PMID:37560165; PMID:36435455; PMID:36929940 |
| GO:0045017 | Glycerolipid biosynthetic process | Decreases phenotype | PMID:38050670 |
| GO:0045023 | G0 to g1 transition | Increases phenotype | PMID:31163220 |
| GO:0045329 | Carnitine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:21673306; PMID:23277027; PMID:24503497; PMID:26188368; PMID:29991372 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:30523571; PMID:36438553; PMID:36610486; PMID:36610486; PMID:36696656 |
| GO:0045540 | Regulation of cholesterol biosynthetic process | Affects phenotype | PMID:33649816 |
| GO:0045541 | Negative regulation of cholesterol biosynthetic process | Increases phenotype | PMID:31262386; PMID:31732953; PMID:38050670 |
| GO:0045542 | Positive regulation of cholesterol biosynthetic process | Increases phenotype | PMID:30550969; PMID:31262386; PMID:31606821; PMID:31706747; PMID:31732953; PMID:34303773; PMID:38050670 |
| GO:0045740 | Positive regulation of dna replication | Affects phenotype | PMID:23793038 |
| GO:0045764 | Positive regulation of amino acid metabolic process | Increases phenotype | PMID:37806616 |
| GO:0045777 | Positive regulation of blood pressure | Increases phenotype | PMID:37734331 |
| GO:0045792 | Negative regulation of cell size | Increases phenotype | PMID:29325824 |
| GO:0045795 | Positive regulation of cell volume | Increases phenotype | PMID:28065941 |
| GO:0045821 | Positive regulation of glycolytic process | Increases phenotype | PMID:37458746 |
| GO:0045833 | Negative regulation of lipid metabolic process | Affects phenotype | PMID:30550969; PMID:34600010 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Affects phenotype | PMID:31163220 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:27853917; PMID:30284816; PMID:32949729; PMID:33711355; PMID:34822940 |
| GO:0046058 | Camp metabolic process | Affects phenotype | PMID:32303808 |
| GO:0046086 | Adenosine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0046101 | Hypoxanthine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0046320 | Regulation of fatty acid oxidation | Affects phenotype | PMID:37806616 |
| GO:0046322 | Negative regulation of fatty acid oxidation | Increases phenotype | PMID:33391822 |
| GO:0046323 | Glucose import | Affects phenotype | PMID:26630026; PMID:28025108 |
| GO:0046325 | Negative regulation of glucose import | Increases phenotype | PMID:30597186 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:32500380; PMID:35510228 |
| GO:0046511 | Sphinganine biosynthetic process | Affects phenotype | PMID:30284816 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:29325824; PMID:30090590; PMID:32050098; PMID:32050098; PMID:32619501 |
| GO:0046651 | Lymphocyte proliferation | Increases phenotype | PMID:23892333 |
| GO:0046676 | Negative regulation of insulin secretion | Increases phenotype | PMID:35550907 |
| GO:0046880 | Regulation of follicle-stimulating hormone secretion | Affects phenotype | PMID:37812459 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:34015638; PMID:37364641 |
| GO:0046889 | Positive regulation of lipid biosynthetic process | Increases phenotype | PMID:34303773; PMID:34600010; PMID:38199361 |
| GO:0048240 | Sperm capacitation | Increases phenotype | PMID:33711355 |
| GO:0048246 | Macrophage chemotaxis | Increases phenotype | PMID:40323316 |
| GO:0048311 | Mitochondrion distribution | Decreases phenotype | PMID:37858774 |
| GO:0048599 | Oocyte development | Decreases phenotype | PMID:28013214 |
| GO:0048666 | Neuron development | Decreases phenotype | PMID:35254616 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:40323316 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:31199487; PMID:33497755; PMID:33846374; PMID:33908429; PMID:36438553; PMID:37734331 |
| GO:0050804 | Modulation of chemical synaptic transmission | Affects phenotype | PMID:37458746 |
| GO:0050810 | Regulation of steroid biosynthetic process | Affects phenotype | PMID:38730545 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:35354077 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:30523571; PMID:30755103; PMID:31606821; PMID:32884073; PMID:33649816; PMID:35970509; PMID:36438553; PMID:36696656; PMID:37979351; PMID:38050670 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:29669060 |
| GO:0051321 | Meiotic cell cycle | Affects phenotype | PMID:30939196 |
| GO:0051567 | Histone h3-k9 methylation | Decreases phenotype | PMID:25975992 |
| GO:0051598 | Meiotic recombination checkpoint signaling | Increases phenotype | PMID:28771232 |
| GO:0051790 | Short-chain fatty acid biosynthetic process | Increases phenotype | PMID:34600010 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:28115068; PMID:31112013; PMID:31175881; PMID:35510228 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Affects phenotype | PMID:23793038 |
| GO:0051898 | Negative regulation of protein kinase b signaling | Increases phenotype | PMID:32710958; PMID:35460826 |
| GO:0051901 | Positive regulation of mitochondrial depolarization | Increases phenotype | PMID:31160972 |
| GO:0055008 | Cardiac muscle tissue morphogenesis | Affects phenotype | PMID:35716406 |
| GO:0055069 | Zinc ion homeostasis | Decreases phenotype | PMID:30755103; PMID:35841924 |
| GO:0055072 | Iron ion homeostasis | Decreases phenotype | PMID:35500696; PMID:39360521 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30056177; PMID:32303808 |
| GO:0055088 | Lipid homeostasis | Decreases phenotype | PMID:32353385 |
| GO:0060008 | Sertoli cell differentiation | Decreases phenotype | PMID:27060630 |
| GO:0060009 | Sertoli cell development | Decreases phenotype | PMID:37059381; PMID:38730545 |
| GO:0060047 | Heart contraction | Increases phenotype | PMID:25351189; PMID:25799571 |
| GO:0060125 | Negative regulation of growth hormone secretion | Increases phenotype | PMID:35550907 |
| GO:0060132 | Prolactin secreting cell development | Affects phenotype | PMID:34728246 |
| GO:0060133 | Somatotropin secreting cell development | Affects phenotype | PMID:34728246 |
| GO:0060135 | Maternal process involved in female pregnancy | Decreases phenotype | PMID:30649530 |
| GO:0060173 | Limb development | Affects phenotype | PMID:28123099 |
| GO:0060206 | Estrous cycle phase | Affects phenotype | PMID:26678702 |
| GO:0060271 | Cilium assembly | Increases phenotype | PMID:33526986 |
| GO:0060283 | Negative regulation of oocyte development | Increases phenotype | PMID:38008054 |
| GO:0060299 | Negative regulation of sarcomere organization | Increases phenotype | PMID:35716406 |
| GO:0060305 | Regulation of cell diameter | Affects phenotype | PMID:37021957 |
| GO:0060376 | Positive regulation of mast cell differentiation | Increases phenotype | PMID:37021957 |
| GO:0060467 | Negative regulation of fertilization | Increases phenotype | PMID:30649530 |
| GO:0060512 | Prostate gland morphogenesis | Decreases phenotype | PMID:31199487 |
| GO:0060618 | Nipple development | Affects phenotype | PMID:37788136 |
| GO:0060713 | Labyrinthine layer morphogenesis | Decreases phenotype | PMID:29753845 |
| GO:0060716 | Labyrinthine layer blood vessel development | Decreases phenotype | PMID:29753845 |
| GO:0060754 | Positive regulation of mast cell chemotaxis | Increases phenotype | PMID:25031359 |
| GO:0060964 | Regulation of mirna-mediated gene silencing | Affects phenotype | PMID:28085963 |
| GO:0060996 | Dendritic spine development | Affects phenotype | PMID:25295592 |
| GO:0061002 | Negative regulation of dendritic spine morphogenesis | Increases phenotype | PMID:34781058 |
| GO:0061107 | Seminal vesicle development | Decreases phenotype | PMID:26168342; PMID:30802670 |
| GO:0061179 | Negative regulation of insulin secretion involved in cellular response to glucose stimulus | Increases phenotype | PMID:33091774 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:23959011; PMID:25882133; PMID:25882133; PMID:30186573; PMID:34197824; PMID:36198370; PMID:26361869; PMID:26361869; PMID:29663635; PMID:27417426; PMID:29663635; PMID:29774754; PMID:31979393; PMID:33983380; PMID:34197824; PMID:34597818; PMID:35196152; PMID:35196152; PMID:39307383; PMID:36198370 |
| GO:0061458 | Reproductive system development | Decreases phenotype | PMID:37788136 |
| GO:0061470 | T follicular helper cell differentiation | Increases phenotype | PMID:25093321 |
| GO:0061517 | Macrophage proliferation | Increases phenotype | PMID:23892333 |
| GO:0061827 | Sperm head | Affects phenotype | PMID:36174316; PMID:39360521 |
| GO:0061956 | Penetration of cumulus oophorus | Decreases phenotype | PMID:36087924 |
| GO:0070091 | Glucagon secretion | Decreases phenotype | PMID:36674557 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:25882133; PMID:28054989 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:35659966 |
| GO:0070276 | Halogen metabolic process | Affects phenotype | PMID:28054989 |
| GO:0070327 | Thyroid hormone transport | Affects phenotype | PMID:33309551 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:16038268; PMID:35739755 |
| GO:0070341 | Fat cell proliferation | Increases phenotype | PMID:25909471; PMID:28105114 |
| GO:0070342 | Brown fat cell proliferation | Increases phenotype | PMID:32522588 |
| GO:0070346 | Positive regulation of fat cell proliferation | Increases phenotype | PMID:30550969; PMID:31262386 |
| GO:0070483 | Detection of hypoxia | Decreases phenotype | PMID:31160972 |
| GO:0070623 | Regulation of thiamine biosynthetic process | Affects phenotype | PMID:31706747 |
| GO:0070730 | Camp transport | Affects phenotype | PMID:26985823 |
| GO:0070859 | Positive regulation of bile acid biosynthetic process | Increases phenotype | PMID:16038268 |
| GO:0070874 | Negative regulation of glycogen metabolic process | Increases phenotype | PMID:34600010 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:21976414; PMID:26845775; PMID:27352406; PMID:28065941; PMID:31160972; PMID:34793900; PMID:34822940; PMID:35196152; PMID:35510228; PMID:35659966; PMID:35818324; PMID:35917956; PMID:39515621 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:35818324 |
| GO:0071493 | Cellular response to uv-b | Affects phenotype | PMID:35887207 |
| GO:0071625 | Vocalization behavior | Affects phenotype | PMID:28934723 |
| GO:0071763 | Nuclear membrane organization | Decreases phenotype | PMID:36087924 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:29029336; PMID:29029336; PMID:34863575; PMID:30755103; PMID:30802670; PMID:31175881; PMID:34015638; PMID:37364641; PMID:39307383 |
| GO:0072574 | Hepatocyte proliferation | Affects phenotype | PMID:25683344; PMID:28065941 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:25418486; PMID:30120713; PMID:30691201; PMID:33526986; PMID:34822940; PMID:35521929; PMID:35659966; PMID:36328110 |
| GO:0072676 | Lymphocyte migration | Increases phenotype | PMID:35917956 |
| GO:0072757 | Cellular response to camptothecin | Decreases phenotype | PMID:30720231 |
| GO:0080009 | Mrna methylation | Increases phenotype | PMID:36423848 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:37545493 |
| GO:0086064 | Cell communication by electrical coupling involved in cardiac conduction | Affects phenotype | PMID:37812252 |
| GO:0090030 | Regulation of steroid hormone biosynthetic process | Affects phenotype | PMID:31709857 |
| GO:0090116 | C-5 methylation of cytosine | Increases phenotype | PMID:19912166; PMID:31211961; PMID:32628958 |
| GO:0090181 | Regulation of cholesterol metabolic process | Affects phenotype | PMID:34438493; PMID:35970509; PMID:37093692; PMID:38199361 |
| GO:0090207 | Regulation of triglyceride metabolic process | Affects phenotype | PMID:31577137 |
| GO:0090357 | Regulation of tryptophan metabolic process | Affects phenotype | PMID:37458746 |
| GO:0097189 | Apoptotic body | Increases phenotype | PMID:37406783 |
| GO:0097198 | Histone h3-k36 trimethylation | Increases phenotype | PMID:37545493 |
| GO:0097202 | Activation of cysteine-type endopeptidase activity | Increases phenotype | PMID:29029336 |
| GO:0097237 | Cellular response to toxic substance | Increases phenotype | PMID:29502735 |
| GO:0097368 | Establishment of sertoli cell barrier | Decreases phenotype | PMID:23892333; PMID:30320191; PMID:36087924; PMID:36174316 |
| GO:0097432 | Hippocampal pyramidal neuron differentiation | Decreases phenotype | PMID:29688563 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:25882133; PMID:30802670; PMID:33711355; PMID:35196152; PMID:35196152; PMID:36174316; PMID:36174316; PMID:39360521 |
| GO:0098743 | Cell aggregation | Affects phenotype | PMID:36198370 |
| GO:0098907 | Regulation of sa node cell action potential | Affects phenotype | PMID:37812252 |
| GO:0110122 | Myotube cell migration | Affects phenotype | PMID:24067726 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:26630026; PMID:30284816; PMID:32325186; PMID:32353385; PMID:34864131; PMID:38092172; PMID:39778647 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:35739755; PMID:37753369 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:36610486; PMID:36774801; PMID:37692514 |
| GO:0140747 | Regulation of ncrna transcription | Affects phenotype | PMID:37003585 |
| GO:0150078 | Positive regulation of neuroinflammatory response | Increases phenotype | PMID:23148021 |
| GO:0150129 | Positive regulation of interleukin-33 production | Increases phenotype | PMID:37545493 |
| GO:0150172 | Regulation of phosphatidylcholine metabolic process | Affects phenotype | PMID:31577137 |
| GO:0150175 | Regulation of phosphatidylethanolamine metabolic process | Affects phenotype | PMID:31577137 |
| GO:0160020 | Positive regulation of ferroptosis | Increases phenotype | PMID:34863575; PMID:35500696; PMID:36438553; PMID:36696656; PMID:38050670 |
| GO:0160024 | Leydig cell proliferation | Affects phenotype | PMID:28611354 |
| GO:1900015 | Regulation of cytokine production involved in inflammatory response | Affects phenotype | PMID:38954831 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:33424850; PMID:35460826; PMID:37545493; PMID:40323316 |
| GO:1900100 | Positive regulation of plasma cell differentiation | Increases phenotype | PMID:25093321 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Affects phenotype | PMID:23793038 |
| GO:1900535 | Palmitic acid biosynthetic process | Decreases phenotype | PMID:37734194 |
| GO:1901033 | Positive regulation of response to reactive oxygen species | Affects phenotype | PMID:23793038 |
| GO:1901142 | Insulin metabolic process | Decreases phenotype | PMID:31606821 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:24140385; PMID:32619501 |
| GO:1901526 | Positive regulation of mitophagy | Increases phenotype | PMID:36583613 |
| GO:1901570 | Fatty acid derivative biosynthetic process | Decreases phenotype | PMID:38050670 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:30755103; PMID:32050098; PMID:32710958; PMID:33348264; PMID:32050098; PMID:32884073; PMID:33120273; PMID:33348264; PMID:33649816; PMID:35460826; PMID:35500696 |
| GO:1901750 | Leukotriene d4 biosynthetic process | Increases phenotype | PMID:35810816 |
| GO:1901992 | Positive regulation of mitotic cell cycle phase transition | Affects phenotype | PMID:23793038 |
| GO:1901994 | Negative regulation of meiotic cell cycle phase transition | Increases phenotype | PMID:35842051 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:33649816 |
| GO:1902721 | Negative regulation of prolactin secretion | Increases phenotype | PMID:25296284; PMID:35550907 |
| GO:1902807 | Negative regulation of cell cycle g1/s phase transition | Increases phenotype | PMID:36423848; PMID:37059381 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:33120273; PMID:33348264; PMID:35739755; PMID:37806616 |
| GO:1902894 | Negative regulation of mirna transcription | Increases phenotype | PMID:37003585 |
| GO:1902902 | Negative regulation of autophagosome assembly | Increases phenotype | PMID:35254616 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:30755103; PMID:32050098; PMID:32710958; PMID:32050098; PMID:35460826 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:19382104; PMID:26361869; PMID:28115068; PMID:31112013; PMID:31175881; PMID:31408635 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:30720231; PMID:31160972; PMID:32884073; PMID:33091774; PMID:33120273; PMID:35500696; PMID:36423848; PMID:36610486; PMID:36610486; PMID:36696656; PMID:39265699 |
| GO:1903537 | Meiotic cell cycle process involved in oocyte maturation | Affects phenotype | PMID:22147016; PMID:28042535 |
| GO:1903726 | Negative regulation of phospholipid metabolic process | Increases phenotype | PMID:34600010 |
| GO:1903786 | Regulation of glutathione biosynthetic process | Affects phenotype | PMID:32949613 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:30523571; PMID:36438553; PMID:36696656; PMID:37979351 |
| GO:1903788 | Positive regulation of glutathione biosynthetic process | Increases phenotype | PMID:33649816 |
| GO:1903863 | P granule assembly | Decreases phenotype | PMID:33754040 |
| GO:1903998 | Regulation of eating behavior | Affects phenotype | PMID:29982774 |
| GO:1904000 | Positive regulation of eating behavior | Increases phenotype | PMID:30660623 |
| GO:1904177 | Regulation of adipose tissue development | Affects phenotype | PMID:37021957 |
| GO:1904445 | Negative regulation of establishment of sertoli cell barrier | Affects phenotype | PMID:29940330 |
| GO:1904598 | Positive regulation of connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:35739755; PMID:37734331 |
| GO:1905053 | Positive regulation of base-excision repair | Increases phenotype | PMID:33120273 |
| GO:1905075 | Positive regulation of tight junction disassembly | Increases phenotype | PMID:36781136 |
| GO:1905166 | Negative regulation of lysosomal protein catabolic process | Increases phenotype | PMID:38488668 |
| GO:1905605 | Positive regulation of blood-brain barrier permeability | Increases phenotype | PMID:37858774 |
| GO:1905642 | Negative regulation of dna methylation | Increases phenotype | PMID:33497755 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:30802670 |
| GO:1905937 | Negative regulation of germ cell proliferation | Increases phenotype | PMID:33754040 |
| GO:1990034 | Calcium ion export across plasma membrane | Increases phenotype | PMID:25799571 |
| GO:1990403 | Embryonic brain development | Decreases phenotype | PMID:25068794 |
| GO:1990428 | Mirna transport | Affects phenotype | PMID:30481674 |
| GO:1990636 | Reproductive senescence | Affects phenotype | PMID:26678702 |
| GO:1990789 | Thyroid gland epithelial cell proliferation | Increases phenotype | PMID:28065941 |
| GO:2000019 | Negative regulation of male gonad development | Increases phenotype | PMID:37979351 |
| GO:2000020 | Positive regulation of male gonad development | Decreases phenotype | PMID:27417426 |
| GO:2000066 | Positive regulation of cortisol biosynthetic process | Increases phenotype | PMID:35550907 |
| GO:2000134 | Negative regulation of g1/s transition of mitotic cell cycle | Increases phenotype | PMID:25369342; PMID:31709857 |
| GO:2000182 | Regulation of progesterone biosynthetic process | Affects phenotype | PMID:25296284 |
| GO:2000183 | Negative regulation of progesterone biosynthetic process | Increases phenotype | PMID:36435455 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:2000224 | Regulation of testosterone biosynthetic process | Affects phenotype | PMID:31709857; PMID:37059381 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:24140385; PMID:29325824; PMID:31923814; PMID:35739735; PMID:37788136 |
| GO:2000253 | Positive regulation of feeding behavior | Increases phenotype | PMID:32784060 |
| GO:2000354 | Regulation of ovarian follicle development | Affects phenotype | PMID:37812459 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:29385306; PMID:31920986; PMID:33234378; PMID:38008054 |
| GO:2000387 | Regulation of antral ovarian follicle growth | Decreases phenotype | PMID:34492810 |
| GO:2000388 | Positive regulation of antral ovarian follicle growth | Decreases phenotype | PMID:28286118 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:36610486 |
| GO:2000408 | Negative regulation of t cell extravasation | Increases phenotype | PMID:36209858 |
| GO:2000409 | Positive regulation of t cell extravasation | Increases phenotype | PMID:36209858 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:32884073 |
| GO:2000439 | Positive regulation of monocyte extravasation | Increases phenotype | PMID:30550969; PMID:34303773 |
| GO:2000466 | Negative regulation of glycogen (starch) synthase activity | Increases phenotype | PMID:30565266 |
| GO:2000609 | Regulation of thyroid hormone generation | Affects phenotype | PMID:33649816; PMID:38522500 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:25596636; PMID:29734584; PMID:32681327; PMID:33789034; PMID:34708313; PMID:35354077; PMID:36005737; PMID:38042133 |
| GO:2000611 | Positive regulation of thyroid hormone generation | Increases phenotype | PMID:34708313; PMID:35228410 |
| GO:2000613 | Negative regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:29734584; PMID:33649816; PMID:36714560 |
| GO:2000614 | Positive regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:30716676 |
| GO:2000670 | Positive regulation of dendritic cell apoptotic process | Increases phenotype | PMID:33424850 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:33908429; PMID:38522500 |
| GO:2000833 | Positive regulation of steroid hormone secretion | Affects phenotype | PMID:31709857 |
| GO:2000839 | Positive regulation of androstenedione secretion | Decreases phenotype | PMID:27405655 |
| GO:2000841 | Negative regulation of dehydroepiandrosterone secretion | Increases phenotype | PMID:30523571 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:29777495; PMID:29777495; PMID:32050098; PMID:30523571; PMID:32533902; PMID:32710958; PMID:34015638; PMID:32050098; PMID:32235866; PMID:37975621; PMID:37839492; PMID:38050670; PMID:39947446 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:30769184; PMID:31709857; PMID:34595713; PMID:37364641 |
| GO:2000848 | Positive regulation of corticosteroid hormone secretion | Increases phenotype | PMID:34051340 |
| GO:2000853 | Negative regulation of corticosterone secretion | Increases phenotype | PMID:34864161 |
| GO:2000863 | Positive regulation of estrogen secretion | Increases phenotype | PMID:34051340 |
| GO:2000864 | Regulation of estradiol secretion | Affects phenotype | PMID:32209209 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:29029336; PMID:31160972; PMID:32533902; PMID:34015638; PMID:34492810; PMID:36435455; PMID:37839492 |
| GO:2000866 | Positive regulation of estradiol secretion | Affects phenotype | PMID:27405655; PMID:30769184; PMID:31771930; PMID:34049116; PMID:37364641 |
| GO:2000870 | Regulation of progesterone secretion | Affects phenotype | PMID:32209209 |
| GO:2000871 | Negative regulation of progesterone secretion | Increases phenotype | PMID:29777495; PMID:31160972 |
| GO:2000872 | Positive regulation of progesterone secretion | Affects phenotype | PMID:27405655; PMID:31771930; PMID:34051340 |
| GO:2001022 | Positive regulation of response to dna damage stimulus | Increases phenotype | PMID:35842051; PMID:36423848 |
| GO:2001038 | Regulation of cellular response to drug | Affects phenotype | PMID:34801851 |
| GO:2001200 | Positive regulation of dendritic cell differentiation | Increases phenotype | PMID:21538406 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.